PetMed Total Liab vs Intangible Assets Analysis
PETS Stock | USD 4.05 0.07 1.76% |
PetMed Express financial indicator trend analysis is much more than just breaking down PetMed Express prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PetMed Express is a good investment. Please check the relationship between PetMed Express Total Liab and its Intangible Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.
Total Liab vs Intangible Assets
Total Liab vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PetMed Express Total Liab account and Intangible Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between PetMed Express' Total Liab and Intangible Assets is 0.73. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of PetMed Express, assuming nothing else is changed. The correlation between historical values of PetMed Express' Total Liab and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of PetMed Express are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Total Liab i.e., PetMed Express' Total Liab and Intangible Assets go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from PetMed Express' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PetMed Express current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.At this time, PetMed Express' Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 100.56 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.15 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 78.1M | 71.0M | 81.7M | 71.6M | Total Revenue | 273.4M | 256.9M | 295.4M | 210.1M |
PetMed Express fundamental ratios Correlations
Click cells to compare fundamentals
PetMed Express Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PetMed Express fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 155.3M | 187.5M | 176.3M | 164.1M | 188.7M | 198.2M | |
Other Current Liab | 4.7M | 5.4M | 5.7M | 11.3M | 13.0M | 13.6M | |
Total Current Liabilities | 24.3M | 44.9M | 33.2M | 36.5M | 42.0M | 44.1M | |
Total Stockholder Equity | 130.0M | 141.3M | 142.2M | 123.8M | 142.4M | 79.3M | |
Property Plant And Equipment Net | 25.4M | 25.5M | 24.5M | 26.2M | 30.1M | 31.6M | |
Net Debt | (103.8M) | (118.7M) | (111.1M) | (104.1M) | (93.7M) | (89.0M) | |
Retained Earnings | 126.2M | 134.1M | 130.5M | 105.5M | 121.3M | 71.7M | |
Accounts Payable | 19.7M | 39.5M | 27.5M | 25.2M | 29.0M | 30.4M | |
Cash | 103.8M | 118.7M | 111.1M | 104.1M | 119.7M | 125.7M | |
Non Current Assets Total | 26.3M | 26.3M | 25.3M | 32.7M | 37.6M | 39.4M | |
Non Currrent Assets Other | (26.3M) | (26.3M) | (25.3M) | 5.9M | 5.3M | 5.5M | |
Cash And Short Term Investments | 103.8M | 118.7M | 111.1M | 104.1M | 119.7M | 125.7M | |
Net Receivables | 3.8M | 2.6M | 1.9M | 1.7M | 2.0M | 1.9M | |
Common Stock Shares Outstanding | 20.1M | 20.1M | 20.4M | 20.3M | 23.4M | 22.4M | |
Liabilities And Stockholders Equity | 155.3M | 187.5M | 176.3M | 164.1M | 188.7M | 198.2M | |
Non Current Liabilities Total | 970K | 1.3M | 936K | 3.8M | 3.4M | 3.6M | |
Inventory | 17.9M | 34.4M | 32.5M | 19.0M | 21.9M | 21.7M | |
Other Current Assets | 3.5M | 4.5M | 5.5M | 4.7M | 5.4M | 5.7M | |
Other Stockholder Equity | 3.8M | 7.1M | 11.7M | 18.3M | 21.0M | 22.1M | |
Total Liab | 25.3M | 46.2M | 34.1M | 40.3M | 46.4M | 48.7M | |
Property Plant And Equipment Gross | 25.4M | 25.5M | 24.5M | 26.2M | 30.1M | 31.6M | |
Total Current Assets | 129.0M | 161.2M | 151.0M | 131.5M | 151.2M | 78.0M | |
Property Plant Equipment | 25.4M | 25.5M | 24.5M | 26.2M | 30.1M | 31.6M | |
Net Tangible Assets | 130.0M | 141.3M | 141.3M | 123.8M | 142.4M | 114.5M | |
Retained Earnings Total Equity | 126.2M | 134.1M | 130.5M | 105.5M | 121.3M | 107.8M | |
Capital Surpluse | 3.8M | 7.1M | 11.7M | 18.3M | 21.0M | 22.1M | |
Other Liab | 1.1M | 970K | 1.3M | 936K | 842.4K | 852.3K | |
Net Invested Capital | 130.0M | 141.3M | 142.2M | 123.8M | 142.4M | 144.4M | |
Net Working Capital | 104.7M | 116.3M | 117.8M | 95.0M | 109.2M | 115.2M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PetMed Express using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for PetMed Stock analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is PetMed Express' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PetMed Express. If investors know PetMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PetMed Express listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 0.9 | Earnings Share (0.37) | Revenue Per Share 13.599 | Quarterly Revenue Growth 0.11 |
The market value of PetMed Express is measured differently than its book value, which is the value of PetMed that is recorded on the company's balance sheet. Investors also form their own opinion of PetMed Express' value that differs from its market value or its book value, called intrinsic value, which is PetMed Express' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PetMed Express' market value can be influenced by many factors that don't directly affect PetMed Express' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PetMed Express' value and its price as these two are different measures arrived at by different means. Investors typically determine if PetMed Express is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PetMed Express' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.